Adriana Elisa Ortega Arriaga is a dedicated researcher and advocate specializing in citizen security and access to justice. Currently pursuing her Master's degree at the Universidad Iberoamericana in Mexico City, she holds a Bachelor's degree in International Relations from ITESM, Campus Chihuahua. Adriana's professional journey includes pivotal roles such as Data Coordinator at renowned feminist organization Intersecta, where she led research projects on security, militarization, and criminal justice impacts with an intersectional feminist approach. She also served as the Department Head at the National Institute of Statistics and Geography, managing significant research and statistical data analysis on public security and judicial administration.
Born and raised in Chihuahua—a region profoundly affected by the war on drugs—Adriana has firsthand experience of the policies' dire impacts on communities, driving her focus on drug policy, health, and human rights. Her latest research, examining the forced internment and release cycles in Ciudad Juárez’s rehabilitation centers, showcases her commitment to challenging systemic human rights violations through rigorous scholarship.
Adriana’s work has been published in various national and international platforms, including Nexos, Animal Político, and The Washington Post. She aims to leverage her expertise at the ISSDP conference to foster global discussions on reforming drug policies to uphold human rights and dignity.

Aileen O'Gorman is Professor of Substance Use and Social Policy and Director of the Centre for Social, Health and Environmental Inequalities Research (SHEIR) at the University of the West of Scotland.
Currently, her primary research focus is on the social, structural and systemic determinants of drug-related deaths. She has a special interest in the framing and problematisation of social issues such as poverty and drug use; the unequal distribution of drug-related harms and deaths in marginalised communities; and the role of policy in the production and reproduction of harms and inequalities.
Aileen is an active participant in policy advocacy and research networks nationally and internationally. She is an elected Trustee of the ISSDP and of UWS Senate, and an appointed member of the Board of the Scottish Drugs Forum and the international editorial board of Drugs: Education, Prevention and Policy.

I am an academic woman and non-injectable substances user who carries out her work from the central west of Mexico. I am a psychoactive mother and I am a member of the Latin American and Caribbean Network of People Who Use Drugs (Mexico LANPUD Network), but I am also a Phd candidate in Sociocultural Studies at the Autonomous University of Aguascalientes, focusing on critical qualitative studies on substance use, mainly substance use stigma and meth use.

Dr. Aleksi Hupli defended his doctoral dissertation in sociology at the University of Tampere in 2021 which focused on cognitive enhancement drug use among students, microdosing psychedelics, and medical cannabis. Currently he works as a post-doctoral researcher at the Emerging Technologies Lab in Tampere University. Hupli’s post doc research focuses on self-medicative use of cannabis in Finland and he also coordinated one of the clinical sites in Finland´s first clinical trial investigating psilocybin-assisted therapy for alcohol use disorder.

Alexa Norton is a PhD Candidate at the University of British Columbia, where she conducts research on the contextual forces that shape the present and future of safe and regulated drugs in Canada ("safer supply").

Alexis Crabtree, MD PhD MPH CCFP FRCPC, is a public health physician with Harm Reduction and Substance Use Services at the British Columbia Centre for Disease Control. She is also Co-Medical Director of the British Columbia Centre on Substance Use and a clinical instructor in UBC School of Population & Public Health. Her clinical duties include medical leadership of British Columbia's take-home naloxone and harm reduction supply programs as well as of the province's drug poisoning public health surveillance system. Her current research includes the Harm Reduction Client Survey, a quality improvement and research project which connects with clients at harm reduction supply distribution sites to learn about their health needs. She is actively involved in research to evaluate public policy to address the unregulated drug poisoning emergency via administrative health data and qualitative research.

Alex Stevens is Professor of Criminology at the University of Sheffield, and a past President of the ISSDP. He leads the Police-led Drug Diversion evaluation with Paul Quinton of the College of Policing and a team of researchers from the Universities of Loughborough, York, Anglia Ruskin, the Open University, the Bradford Institute of Health Research and User Voice.

Professor Alison Ritter, AO is a drug policy scholar and Director of the Drug Policy Modelling Program at the Social Policy Research Centre, UNSW, Sydney. She conducts research on drug laws, drug treatment, models and methods of democratic participation in drug policy; and research focussed on policy process. Her work is supported by grants from competitive research funding bodies (NHMRC, ARC) as well as commissioned research from governments across Australia and internationally. She is past President of the International Society for the Study of Drug Policy, and Editor for the International Journal of Drug Policy. Professor Ritter has an extensive research grant track record and has published widely in the field.

Allison Korn is a Clinical Professor of Law and Director of the Health Justice Clinic at Duke University School of Law. She joined the Duke Law faculty in 2022 from UCLA School of Law, where she was the assistant dean for experiential education and director of the Food Law & Policy Clinic.

Korn’s teaching and scholarship focus on law, policy, and practices that impact vulnerable individuals’ and communities’ access to justice, including the collision of the U.S. healthcare and criminal legal systems. She also writes about emerging methods in clinical teaching.

Korn began her academic career as a Clinical Teaching Fellow at the University of Baltimore School of Law. As a practitioner, she was a member of the inaugural class of family defense attorneys at the Bronx Defenders in New York, representing parents charged with abuse and neglect and fighting against unnecessary removal of children from their families. As a staff attorney with Pregnancy Justice (formerly National Advocates for Pregnant Women), Korn advocated for the rights and dignity of pregnant and parenting persons prosecuted for drug use.

Korn is a graduate of Roanoke College, where she was the David Bittle Scholar, and earned her J.D. from the University of Mississippi School of Law. While in law school, Korn co-founded the Student Hurricane Network, a national network of more than 5,500 law students advancing the cause of social justice in communities affected by Hurricanes Katrina and Rita.

Amanda has over 20 years experience in the AOD research sector, with a national and emerging international profile relating to her expertise in opioid overdose mortality. She is currently leading a program investigating the drivers of fatal and non-fatal overdose in the context of changing drug markets, and also collaborates on research with the Sydney Medically Supervised Injecting Centre.

Anastasia is a PhD student in the School of Public Health Sciences at the University of Waterloo.

Anke Stallwitz is Professor of Social Psychology at the Protestant University of Applied Sciences Freiburg, Department of Social Work . She has conducted numerous studies on drug scenes and drug markets in Germany, Puerto Rico, Sweden, Canada and the UK, focussing on social structures, socio-political embedding, violence (e.g. in the drug trade and against women) and peer interventions. Further focal points in research, teaching and practice are drug policy, prevention (cannabis and drugs in general), drugs and migration, participatory approaches in research, intervention, and policy as well as organised drug-related crime.

Anna Ross completed her PhD in Sociology at the University of Edinburgh with a focus on drug policy stakeholder engagement. She has worked for the UK Government as Special Advisor to the Scottish Affairs Committees Inquiry into Problem Drug Use in Scotland, in addition, she has been on a range of drug policy advisory committees in Scotland, set up the Scottish Drug Policy Conversations: a multi-stakeholder deliberative group exploring drug policy issues in Scotland, is co-founder of the Scottish Psychedelic Research Group, was secretary to the Cross Party on Medicinal Cannabis, founder of the Scottish Cannabis Consortium, and co-convener of the Drugs Research Network Scotland (DRNS): a Scottish government funded drugs research network.

Dr Anne Campbell is a Professor in Substance use at QUB . She has established an international reputation for work within the drugs and alcohol sector. Her combined work in both arenas has resulted in distinctive and leading research at UK Government level drug policy and practice reform. She is currently working on ‘wearables technology ’ to detect opioid overdose deaths , labelling for alcohol products using face recognition software and community approaches to addressing substance use issues.

Indiana State University, School of Criminology & Security Studies

Dr. Ashley Hosker-Field is a professor in the Criminal Justice, Bachelor of Social Science program at Humber Polytechnic. She received her Ph.D. in Social Personality Psychology where her graduate education was supported by Joseph-Armand Bombardier Canada Graduate Scholarships. Dr. Hosker-Field’s research interests are varied and have focused on examining psychopathic traits, impulsivity, risk-taking, empathy, fear and aggression. Since joining the Humber faculty team in 2019, Dr. Hosker-Field has been a co-investigator on several NSERC funded research projects. These research initiatives include the examination of interagency collaboration and evaluation of youth focused social services, as well as the provision of evidence informed, stigma-free cannabis related education to various populations. Dr. Hosker-Field has also been involved in consulting projects commissioned by the Mental Health Commission of Canada and the Canadian Centre for Substance Use and Addiction.

Ava is a PhD student in the School of Public Health Sciences at the University of Waterloo. She graduated from Wilfrid Laurier University with a BSc in Psychology and Neuroscience and a specialization in research, where she explored risk perceptions towards cannabis use among post-secondary students.

Beau Kilmer (he/him) is codirector of the RAND Drug Policy Research Center, a senior policy researcher at RAND, and a professor of policy analysis at the Pardee RAND Graduate School.

His research lies at the intersection of public health and public safety, with special emphasis on substance use, illegal markets, crime control, and public policy. Some of his current projects include assessing the consequences of cannabis legalization (with a special focus on social equity); measuring the effect of 24/7 Sobriety programs on impaired driving, domestic violence, and mortality; analyzing changes in illegal fentanyl markets; and considering the implications of legalizing psychedelics.

Kilmer's publications have appeared in the New England Journal of Medicine, Proceedings of the National Academy of Sciences, and Science. His commentaries have been published by CNN, Los Angeles Times, New York Times, San Francisco Chronicle, USA Today, Wall Street Journal, among others. Two editions of his coauthored book on cannabis legalization were published by Oxford University Press; his coauthored book on the future of fentanyl and other synthetic opioids was published by RAND.

Kilmer is a member of the National Academy of Sciences, Engineering, and Medicine Committee on Public Health Consequences of Changes in the Cannabis Policy Landscape. In 2023, he was elected as vice president of the International Society for the Study of Drug Policy. He received his Ph.D. in public policy from Harvard University, M.P.P. from UC-Berkeley, and B.A. in international relations from Michigan State University.

Ben Senator is a Ph.D. candidate at Pardee RAND Graduate School and an assistant policy researcher at the RAND Corporation, and formerly a research assistant at RAND Europe. His research interests lie in the public health, social, and criminal justice impacts of regulatory approaches to legal and illicit substances. Senator has supported multiple projects with the RAND Drug Policy Research Center, with his current work concerning de jure non-medical cannabis policy developments, the effectiveness of policy responses to the U.S. opioid epidemic, alternative policy options to psychedelic drug prohibition, and the Dutch cannabis supply chain pilot. He also maintains a focus on broader social policy research, with current work researching veterans' housing and crisis support.

Social drug researcher since 1999, full professor for social work since 2024

Dr Bisi Akintoye is a lecturer and solicitor whose research focuses on the intersection between race, drugs, policing, and youth experiences. Her research explores the role played by race and racism in the policing of Black communities through exploring lived experience. She qualitatively approaches the intergenerational lived experience of racialised policing by the police, through the prism of structural racism within colonial and post-colonial contexts. Her research prioritises how race and structural inequalities intersect with issues of policing, youth justice, and drugs. Bisi’s work applies an intersectional equity lens to racialised drug policing, and analyses how ethnicity, gender, age, class, and immigration histories affect drug policing experiences.

Caitlin is an Associate Professor in criminology and drug policy and Matthew Flinders Fellow at Flinders University. Her research seeks to advance Australian and international drug policy by improving the evidence-base into the effects of different legislative and law enforcement approaches to drug use and supply and working directly with policy makers. Caitlin is also President of the International Society for the Study of Drug Policy.

Caitlin is a PhD candidate at The University of Queensland’s School of Psychology and the National Centre for Youth Substance Use Research, supported by a UQ Research Training Program Scholarship. Driven by a commitment to substance use research, Caitlin's research focuses on evaluating the effectiveness of harm reduction interventions in enhancing knowledge about cannabis use and its associated risks. Through this work, Caitlin aims to contribute to the development of evidence-based approaches that promote safer substance use behaviours among young people.

Carla Treloar is Scientia Professor at the Centre for Social Research in Health at UNSW, Sydney Australia. Carla has published more than 300 peer-reviewed papers. She is co Editor in Chief of the International Journal of Drug Policy and served as senior editor for qualitative research for Addiction from 2018-2024.

Catherine Arseneault is a professor at the School of Criminology at the Université de Montréal. Her research focuses on the relationship between drugs and crime, examining both individuals who engage in these behaviors and the services available to them. Her work explores the intersections of substance use, criminal justice interventions, and social policies, with a particular emphasis on evidence-based approaches to treatment and rehabilitation.

Catherine Cook is the Sustainable Financing Lead at Harm Reduction International (HRI).

Catherine is an expert on the funding of harm reduction. She has developed a portfolio of ground breaking research and policy analysis on financing for harm reduction, including the tracking of donor and government investment in harm reduction. She has coordinated international research, developed tools for harm reduction advocates and provided regular analysis to United Nations and donor agencies.

Catherine was responsible for conceptualising and developing HRI’s flagship project, the Global State of Harm Reduction in 2007.

Catherine brings 17 years of professional experience in harm reduction, HIV and policy research and has published extensively on a wide range of topics related to harm reduction and public health in both civil society reports and academic literature.

Charlie Lloyd is a Professor of Criminal Justice and Social Policy at the University of York, England, and is also Deputy Director of the Vulnerability and Policing Futures Research Centre. He has undertaken research over the past 35 years on a wide range of drug-related topics, including policing drugs and out-of-treatment drug users.

Chelsea L. Shover, PhD is an Assistant Professor at the David Geffen School of Medicine at UCLA, where she directs the Epidemiology, Policy, and Implementation Lab (EPI Lab). The EPI Lab’s work unites quantitative data analysis with community based participatory research on overdose, substance use disorders, infectious diseases, and homelessness. Dr. Shover completed her PhD in epidemiology at the UCLA Fielding School of Public Health, followed by a postdoctoral fellowship in Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Shover’s team has identified key U.S. drug supply changes (i.e., fentanyl’s westward spread, emergence of xylazine, rapid introduction of industrial chemical BTMPS into the illicit fentanyl supply) and then worked with policymakers and community organizations to improve on-the-ground overdose prevention. She was awarded a K01 career development award in 2021, and an R01 from the National Institute of Health’s Helping End Addiction Long-Term Initiative in 2022. Dr. Shover’s work is currently funded by the National Institute on Drug Abuse and Centers for Disease Control and Prevention to improve overdose surveillance in Los Angeles and operate a drug checking program at syringe services programs. She is an Associate Editor for Addiction. Alongside her academic research, Dr. Shover has worked in local government, community clinics, and policy advising capacities, all of which inform her team’s approach to urgent and complex public health problems. In 2021, she collaborated with local and state public health partners to arrange LA50K, a pilot program of 50,000 naloxone kits to distribute to people experiencing homelessness in Los Angeles. As a member of the Stanford-Lancet Commission on the North American Overdose Crisis, she co-authored a report published in the Lancet in 2022 and has given international briefings on the report’s recommendations. In 2023, she was invited to join a working group of the United Kingdom’s Advisory Council on the Misuse of Drugs to contribute to a report making recommendations to prevent public health harms associated with xylazine. She has continued to engage with the Home Office about emerging substances. As an educator, Dr. Shover is especially committed to mentoring trainees from underrepresented in science, including people with personal experience of substance use disorders and mental illness.

Dr Cheneal Puljevic is an ARC DECRA Senior Research Fellow at the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame at the School of Public Health. Her current research focuses on the drivers and deterrents of illicit tobacco use. Cheneal is also the Queensland Research Lead for The Loop Australia, a core team member for the Global Drug Survey, an Associate Editor for the International Journal of Drug Policy, and a Deputy Editor for Drug and Alcohol Review.

Chris Dalby is a seasoned investigative journalist and director of World of Crime, a consultancy specializing in organized crime and transnational drug trafficking. With over a decade of experience, including as a former managing editor at InSight Crime, Chris has extensively researched how drug trafficking dynamics evolve over time. He is the author of "CJNG - A Quick Guide to Mexico's Deadliest Cartel" and the editor-in-chief of the Sports and Crime Briefing.

In 2024, Chris advised the White House Office of National Drug Control Policy, the UK National Crime Agency, and France’s Office Anti-Stupéfiants on emerging narcotics threats. His fieldwork spans Latin America, Europe, and the UK, uncovering critical vulnerabilities in port security and customs processes.

Chris Rintoul has 30 years’ experience in working with people who use drugs and with people who experience homelessness, 25+ of those years as a social worker. He has a particular interest and expertise in harm reduction approaches, with 20+ years’ experience in the delivery of harm reduction training to staff working in a wide range of sectors/orgs whose work brings them into contact with substance users. Chris has set up harm reduction services such as outreach and specialist accommodation services. With Cranstoun, Chris has led on the development of it’s naloxone training, injecting equipment provision and response to novel synthetic opioids. He has an interest in the role technology can play in reducing harm, developing the 1st interactive overdose response app in 2012 and now leading on a wearable overdose detection device and alert system, currently in live trial. Along with peers in similar roles within other UK treatment providers, he developed Stayin’ Alive resources in response to the nitazenes threat which emerged in 2023. Chris has written a range of practical resources for frontline workers and people who use substances on nutrition, benzodiazepines, pregabalin, opioids, naloxone, polydrug use and medications management. He has been involved in writing a number of articles:
• Naloxone report (publishing.service.gov.uk) ACMD 2022
• Groin Injecting in Northern Ireland: Views of the Experts by Experience — Queen's University Belfast (qub.ac.uk) QUB 2021
• A rapid assessment of take-home naloxone provision during COVID-19 in Europe - ScienceDirect IJDP 2022
• Reducing Opioid Related Deaths for individuals who are at high risk of death from overdose: A co production study with people housed within prison and hostel accommodation - by Campbell, Anne; Millen, Sharon; Guo, Li; Jordan, Uisce; Taylor Beswick, Amanda; Rintoul, Chris; Diamond, Aisling.

Professor Chris Wilkins is the leader of the drug research team at Massey University. Chris has expertise in drug trends, drug markets, and drug policy and evaluation. Over the past twenty years, he has completed a range of studies with particular focus on methamphetamine, cannabis, NPS, ecstasy, and organized crime and drug market structure. He has published over 100 academic articles on a range of topics related to drug use, drug-harms and policy response, including recently co-editing an international book evaluating cannabis legalization reforms (Legalizing Cannabis: Experiences, Lessons and Scenarios, with Professors Tom Decorte and Simon Lenton).

Cláudia Costa Storti works at the European Union Monitoring Centre in Lisbon and her main interests are the economic aspects of drug policy.

She is currently in charge of analysing the socioeconomic determinants of the drug phenomenon, impact of economic cycle and the public costs of drug-related policy and the impact of the economic recession.

The analysis of drug markets has also been part of her duties, leading to the publication of scientific articles in drug-related journals, editorials in MIT books and other EMCDDA technical papers.

She holds an MSc in Economics from the Catholic University of Leuven, Belgium, and a degree in Economics from the Universidade Nova de Lisboa, Portugal.

Clemence Rusenga is a Teaching Associate in the School of Social Sciences, Cardiff University, United Kingdom. His research interests focuses on the nexus between drugs, livelihoods and development in African contexts. He was a Senior Research Associate in a multi-nation research team working on African drug policy on cannabis and its implications for livelihoods and national development in Kenya, Nigeria, South Africa and Zimbabwe as part of the Cannabis Africana: Drugs and Development in Africa project located at the Universities of Bristol and Cape Town.

Dr. Cléssio Moura de Souza was born in Traipu, Brazil. He studied law at the Pontifical Catholic University of Rio de Janeiro before obtaining his Master of Laws (LL.M.) at the University of Freiburg, Germany. In 2019, he concluded his doctoral research at the International Max Planck Research School on Retaliation, Mediation, and Punishment at the Max Planck Institute for Foreign and International Criminal Law. He was a postdoctoral research assistant at the Institute for Geography at the University of Erlangen- Nürnberg (2020–2022). He has lectured as a visiting professor at Pompeu Fabra University in Barcelona (2021) and as an assistant professor at Lusíada University of Porto (2019–2020). He currently works as a Criminology and Criminal Justice Lecturer at the University of the West of Scotland (UWS).

Cristina Temenos is a Reader in Human Geography and a UKRI Future Leaders Fellow. Her research is focused on health inequalities and the politics of access to care in cities globally. She is one of the first scholars working in the field of policy mobilities, a new approach to knowledge translation, and she has developed this work in relation to drug use and treatment, public health, housing, economic austerity, environmental sustainability, transport, and climate change. Cristina’s research analyses the relational politics of public health and social reproduction in cities across the so-called 'global north' and 'global south'. Current work examines the effects of post 2008 austerity policies of public health services and intersecting heath, economic and social crises across Latin America and Europe. Her research also engages these interests through a focus on the geographies of harm reduction drug policy and the ways that social movements produce and mobilize knowledge about health and human rights to advocate for policy change in cities.

-

Prof. David Décary-Hétu has a Ph.D. in criminology from the Université de Montréal (2013). He first started as a Senior Scientist at the School of Criminal Sciences of the Université de Lausanne before moving to his current position as an Associate Professor at the School of Criminology of the Université de Montréal. The main research interests of Prof. Décary-Hétu focus on the impacts of technology on crime. Through his innovative approach based on big and small data, as well as social network analysis, Prof. Décary-Hétu studies how offenders adopt and use technologies, and how that shapes the regulation of offenses, as well as how researchers can study offenders and offenses. Prof. Décary-Hétu is the Chair of the Darknet and Anonymity Research Centre (DARC) that was funded by the John R. Evans Leaders Funds from the Canada Foundation for Innovation. His team collects and studies data from all types of offenders who use anonymity technologies such as the darkweb, cryptocurrencies and encryption. Prof. Décary-Hétu has received funding from both public and private grantors operating at the local, provincial, federal and international level. He has published in leading academic journals and is invited regularly in the news media to comment on recent events. Prof. Décary-Hétu is involved in many partnerships and initiatives including Open Criminology, the revue Criminologie, the Division of Cybercrime of the American Society of Criminology and the Human-Centric Cybersecurity Partnership.

Davide is a researcher at University of Lille (LEM) where his postdoc focus on the impact of heroin shortages on French users through longitudinal surveys, toxicological analysis and the study of darkweb. He obtained his PhD at Pantheon-Sorbonne University exploring the economics of cannabis regulation and focusing on its integration into the European Health System and the emergence of the market for cannabidiol. Davide is member of the Global Cannabis Cultivation Research Consortium as he’s interested in better understanding domestic cannabis cultivation. Consultant at the United Nations Office for Drugs and Crime on the analysis of drug market sizing and trafficking, Davide is an adjunct lecturer at the University of Padua on medical cannabis economics. He collaborates with MPG Consulting to advise governments in designing cannabis markets.

-

With a background in development cooperation, Deborah Alimi is an expert researcher on global drug policy evolution, specializing in the intersections between illicit economies, sustainable development, and policy coherence. In 2020, she founded Daleth Research (Drug Policy AnaLysis Evaluation & Thinking), an Paris-based initiative dedicated to advancing scientific and policy debates on organized crime/drug policies, human rights, and sustainable development through research and cross-sectoral collaboration. Deborah serves as an independent consultant to governmental and international organizations, including the UNODC, OHCHR, the EU, COPOLAD, and the Global Partnership on Drug Policies and Development (GPDPD). She also leads the "Drugs, Development and Human Rights" workstream for the Drugs, Social Sciences and Societies (D3S) Program at EHESS, a research network she coordinates. Deborah is a graduate of Georgetown University (Washington, D.C.) and holds a PhD in political science from Université Paris 1 Panthéon Sorbonne (Paris).

I am an associate professor and health services researcher in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University. I hold a Canada Research Chair (Tier 2) in the Economics of Harm Reduction. I evaluate the effects of harm reduction interventions and drug policies implemented in Canada using publicly available or administrative health data.

Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. Elle is also a senior analyst at RAND Europe, working on projects focusing on national and international drug policies. She holds a PhD in public health and health systems from the University of Waterloo (Canada), an MSc in addiction studies from King's College London (UK), and a BSc in chemistry from the University of Bristol (UK).

Dr. Eric L. Sevigny, Professor and Interim Chair in the Department of Criminal Justice and Criminology at Georgia State University, conducts policy-relevant research at the intersection of drugs, crime, and society. His research program encompasses three primary areas: drug policy and public health, where he examines the impacts of drug laws and enforcement practices; criminal justice policy evaluation, focusing on interventions like drug courts and sentencing policies; and quantitative methods, where he has developed innovative approaches to measuring drug markets and their consequences. Through research supported by the National Institute on Drug Abuse, the Office of National Drug Control Policy, and other major institutions, Dr. Sevigny has made significant contributions to understanding the effects of marijuana liberalization policies, developing composite indices for measuring drug-related consequences, and advancing methodologies for analyzing drug market dynamics, with his work appearing regularly in leading criminology and policy journals.

Farzaneh Vakili is a PhD candidate in Biomedical Sciences in the Département de Médicine Familiale et Médecine d’Urgence at the Université de Montréal. She studies under the supervision of Dr. Sarah Larney and Dr. Julie Bruneau at the Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CrCHUM). Farzaneh has a MSc in Midwifery from Tehran University of Medical Sciences, Tehran, Iran. She has seven years of research experience, including four years working on health among women living with HIV/AIDS. Farzaneh's current research aims to investigate the associations between gender, unstable housing, and hepatitis C in people who inject drugs through an epidemiological and biostatistical approach.

Fay Dennis is a Wellcome Trust Senior Research Fellow at Goldsmiths, University of London. Fay's work explores the socio-material effects of illicit and licit drug use, with a particular interest in inventive methods.

Filippo Andrei obtained his PhD in Sociology and Social Research from the University of Trento in March 2024, with a thesis titled “Unveiling the Shadows: A Cognitive Approach to Understanding Social Influence Strategies for Establishing Social Order in Darknet Markets.” His research focuses on the social mechanisms that create biases in the digital world, investigating how social and cognitive structures influence decision-making. His work has been published in international journals, including the European Sociological Review and the International Journal of Drug Policy.

Professor Fiona Measham has been Chair in Criminology at the University of Liverpool since 2019. She has spent over three decades researching trends in drug use, their relationship with drug policy and the wider socio-cultural contexts to use. Fiona has authored and co-authored over 100 publications, most recently exploring aspects of drug cultures, harm reduction and the interface of drugs and sexuality, as well as engagement in nightlife, underpinned by critical understandings of policy change and social justice. Fiona is co-founder and trustee of The Loop (2012-) and The Loop Australia (2018-), award-winning charities best known for introducing drug checking services in the UK and three Australian states.

Gernot Klantschnig is Professor of International Criminology at the University of Bristol and conducts research on drugs, drug policy, illicit livelihoods, organised crime and related policing in West Africa.

Giovanni Trovato is Full Professor of Economic Statistics at the dept. of Finance and Economics. Prof. Trovato has published numerous papers in leading peer-reviewed journals (among others: Journal of Applied Eocnometrics, Econometrics Journal, Journa of Regional Science, Journal of Money, Credit and Banking, Macroeconomic Dynamics, Journal of Health, etc.) . His work focuses on the impact of fiscal policies, labor markets, and economic inequalities. Some of his most notable publications include studies on the efficiency of public spending and the relationship between education and economic development

Greg Midgette is a senior policy researcher at RAND and an associate professor of criminology and criminal justice at the University of Maryland. He specializes in program evaluation, policy analysis, and empirical research methods. His work focuses on alcohol and drugs, illicit markets, community corrections, the impact of public safety policies and practices on public health, and the influence of policy design on disparities.

Dr. Hadi Daneshvar is a Lecturer in Clinical Health Technologies in the School of Health and Social Care at Edinburgh Napier University and a member of the Healthcare Technology Research Group. He has delivered lectures, tutorials, and workshops to postgraduate students, researchers, and clinicians.
Hadi received a PhD in Health Informatics from the School of Informatics at the University of Edinburgh. Additionally, his background includes Business Information Technology (MSc), Information Systems (BSc), and Software Engineering. Before joining Edinburgh Napier University, he was a Research Fellow in the Faculty of Social Science at the University of Stirling and a postdoctoral research assistant at the University of Dundee. His research at the University of Stirling focused on the delivery of technology to prevent overdose deaths in Scotland, leading various projects in this area.
Hadi's research interests lie in the field of health informatics, with a particular focus on developing and evaluating new technologies (particularly in drug overdose prevention), Artificial Intelligence (AI), Information Systems, Co-production, Digital Health Interventions, and social media in health and care. Additionally, he has experience in research on Socio-Technical Systems, Human-Computer Interaction (HCI), and Knowledge Management in digital/online environments for collaborative work purposes.

Dr Helen Beckett Wilson is a Senior Lecturer and Researcher from the School of Justice Studies and Law at Liverpool John Moores University. She is a member of LJMU's Centre for the Study of Crime, Criminalisation and Social Exclusion. Helen's research focuses on criminal justice and drug policy analysis. In MedCan Project, she works in partnership with Dr Lindsey Metcalf McGrath, researching and highlighting the experiences of people who take cannabis medicine in the UK.

Helen Redmond is a Harlem-based documentary filmmaker, journalist, and a licensed clinical social worker. Helen is a senior editor and a multimedia journalist at Filter. She has written extensively about methadone. An expert on drug addiction and treatment, she is an adjunct assistant professor at New York University. Her feature-length film, Liquid Handcuffs: A Documentary to Free Methadone, was screened in the U.S. and internationally. Helen toured her short doc, Swallow THIS: A Documentary About Methadone & COVID-19 across the U.S. and Canada in 2023.

Hudson Reddon, PhD is a Research Scientist at the BCCSU and Assistant Professor at the University of British Columbia, Faculty of Medicine.

At the BCCSU, Dr. Reddon’s research focus is to conduct innovative longitudinal research to elucidate the risks, as well as the potential benefits, of evolving cannabis use/access patterns among people at highest risk of overdose and other substance-related harms during the fentanyl era. He has an established track record of attracting research funds as a principal investigator or co-applicant (Canadian Institutes of Health Research, Public Health Agency of Canada) and has published numerous peer-reviewed scientific papers in high impact academic journals including Clinical Infectious Diseases, American Journal of Public Health and Lancet HIV. Dr. Reddon has a keen interest in teaching and completed a Bachelors of Education degree at the University of Toronto. He has been involved in the design and delivery of curriculum among undergraduate and graduate students in the areas of health equity and chronic disease management at UBC and Trinity College Dublin. Dr. Reddon holds a Michael Smith Health Research BC Scholar Award and received his graduate training at McMaster University in Health Research Methodology and Clinical Epidemiology. He is an active member of the Canadian Society of Addiction Medicine, the International Cannabinoid Research Society and the Canadian HIV Trials Network.

I am a Colombian economist currently completing my master’s thesis in Economics, with an expected graduation in 2025. My academic journey began with research on the urbanization processes in a Colombian city, which was later published as a book chapter. For the past year, I have been part of a research team working on the "Semillas de Apego" project, aimed at improving children's mental health and development through socioemotional interventions for caregivers. Initially designed for areas affected by the Colombian conflict, the program's results have led to its scaling up at the national level. As a Research Assistant, I contributed to the evaluation of the pilot program and am now involved in the impact evaluation of the nationwide implementation. My broader research interests include exploring how governmental interventions and vulnerable contexts (violence, poverty, scarcity) shape the mental health and development trajectories of children. My thesis leverages randomized data from the Semillas de Apego pilot to evaluate the impact of drug policy on the mental health and development outcomes of children under five. Throughout my training, I have developed expertise in quantitative methods, particularly in data management, analysis, and causal inference techniques. Moving forward, I aim to deepen my knowledge of childhood development conceptual frameworks and other methodologies to conduct research in this field.

Isabelle Volpe is a PhD candidate at the Drug Policy Modelling Program, which is part of the Social Policy Research Centre at UNSW Sydney in Australia. Her PhD research uses critical social science approaches to explore the intersection of young people, drugs, policy and participation. Isabelle’s research more broadly has included clinical trials, treatment guidelines, and co-designing of health promotion interventions. Isabelle is also a research officer at the Social and Global Studies Centre (RMIT University), conducting mixed-methods research on drug alerts and drug checking. She puts this research into practice as the Communications Lead at a drug checking charity, The Loop Australia.

Ivana Obradovic is the Deputy Director of the French Monitoring Centre for Drugs and Drug Addiction (Observatoire français des drogues et des tendances addictives) and an Associate Researcher at university UVSQ / Centre de recherches sociologiques sur le droit et les institutions pénales (CESDIP). Her main research interests are focused on drug policy models and cannabis policy issues. She has recently supervised a cannabis policy research project focused on the comparison between cannabis regulatory regimes developed in 6 jurisdictions in North America (Washington, Oregon, California in the US & British Columbia, Ontario, Quebec in Canada).

Jack Farrell is a 4th year PhD student at the School of Criminology whose research is interested in exploring the ideological barriers that impede progressive drug policy change. Through working with communities that have borne the brunt of the War on Drugs, Jack seeks to both highlight the deadly consequences of current drug policy and to co-develop drug policies that prevent rather than cause harm.

Dr Jack Spicer is a Senior Lecturer in Criminology at The University of Bath. He has written extensively on the emergence of 'County Lines' drug supply onto the policy landscape, the practice of 'cuckooing' and the associated responses. This reflects his wider research interests into the functioning of illicit drug markets, the enforcement of drug laws and drug policy reform.

Dr Jane Mounteney is Head of Unit at the EU Drugs Agency

Director of D2 INNO-LAB, the Global Innovation Lab on Drug Policy and Sustainable Development, and fellow researcher for the Global Governance Research Center (CIGG) of the University of Salamanca (Spain).

In the past 25 years, he worked as director of the EU-LAC drug policy cooperation program (COPOLAD III), as regional LAC advisor on Citizen Security and Democratic Governance at the UN Development Programme, as senior expert on drug policy for the EU in Bolivia and for the Organization of American States in key areas of drug policy development, as well as an independent advisor in Latin America and Southeast Asian countries.

Javier holds a law degree from the Universities of Salamanca (Spain) and Galway (Ireland), a Master's degree in European Law from the Free University of Brussels (Belgium), a postgrad in decentralization and local development from the Alberto Hurtado University in Chile, and PhD courses on Social Economy at the University of Valencia (Spain).

Dr. Jayani Jayawardhana is a health economist and an Associate Professor in the Department of Health Management and Policy in the College of Public Health at the University of Kentucky (UK). She is also jointly appointed as Associate Professor in the Department of Pharmacy Practice and Science in the College of Pharmacy at UK. She earned her Ph.D. in economics from the University of Virginia. Her research focuses on the intersection of public policy and substance use research. Her work has been funded by the National Institute on Drug Abuse, the National Cancer Institute, and a variety of research foundations including the Robert Wood Johnson Foundation. Dr. Jayawardhana’s research work contributes to advancing the scientific knowledge and informing policy makers on the effectiveness of public policies in achieving better substance use related health outcomes. Her research has been published in JAMA Psychiatry, Health Services Research, Medical Care, and American Journal of Public Health.

PhD Researcher and Graduate Teaching Fellow at the University of Liverpool, researching County Lines drug supply and UK drug policy

Dr. Jennifer Donnan is an Associate Professor with Memorial University School of Pharmacy. A pharmacist by training, her focus now is on cannabis policy and substance use prevention and harm reduction among youth. Jennifer has co-developed the Drug Education Centered on Youth Decision Empowerment (DECYDE) strategy. This comprehensive strategy includes educator training, lesson plans and activities for use in the classroom, and is expanding to include meaningful support for caregivers. She is also does pharmacy practice research focusing on the role of pharmacists in delivering cannabis related care. Jennifer is passionate about training the next generation of pharmacists to provide true patient centered care that challenges stigma, is culturally sensitive and trauma informed.

Jessica Storbjörk is Associate Professor of Sociology and Senior Lecturer at the Department of Public Health Sciences, Stockholm University. She currently serves as the Director of the Centre for Social Research on Alcohol and Drugs (SoRAD). Her research centers around substance use treatment systems, harm reduction, policy, and the marketization of health and welfare services. ORCID: 0000-0002-1757-9974

I am a criminology lecturer at Manchester Metropolitan University and a PhD criminology student at the University of Manchester exploring harm reduction initiatives at music festivals in the UK. With an interest in recreational drug use, drug policy, dance spaces and harm reduction, I aim to contribute to disciplinary knowledge and understanding of contemporary drug, crime and policing issues to advocate for harm reduction policing and initiatives and enhance pleasure, safety and inclusivity in contemporary dance spaces.

John is Director of Academic Engagement at the Global Initiative Against Transnational Organized Crime, based in our office in Vienna.

John also serves as Editor-in-Chief of the Journal of Illicit Economies and Development (JIED), LSE Press, and Board member of the International Society for the Study of Drug Policy (ISSPD). He is a Fellow at the Centre for Criminology at the University of Hong Kong and a Visiting Fellow at Shanghai University.

At GI-TOC, John leads a series of academic engagement projects, including serving as Chair of the Steering Committee of the International Association for the Study of Organized Crime (IASOC); Research Coordinator for our collaboration with the SOC ACE project hosted by the University of Birmingham; GI-TOC lead for our Drugs and Development Hub collaboration with GIZ GPDPD; and coordinator for a major Open Society Foundations project examining the intersection of drug policy reform and organized crime. John has focused on building research and policy capacity in a number of core GI-TOC focus areas, including West Africa, Ukraine, Colombia, Brazil, East and Southeast Asia and Afghanistan.

Before joining the GI, John was Founding Executive Director of the LSE’s International Drug Policy Unit (IDPU), a Fellow of the LSE US Centre and a Distinguished Visiting Fellow of the Yale Centre for the Study of Globalization.

John’s historical research focuses on the political economy of international drug control. He earned a PhD from the Department of International History at the London School of Economics. John’s contemporary policy interests focus on the political economy of international drug control and the evolving dynamics on national and international policy reforms. In 2022 he published a book on the Regulatory History of UN Drug Control with Cambridge University Press.

John-Peter Kools is an international expert on substance use, drug policy and public health.
Kools has been involved in the drug field for 4 decades. He was involved in developing the first HIV prevention and health programs for people who use drugs in his hometown of Amsterdam. He works as a senior policy advisor at the Dutch Trimbos Institute where he leads the international drugs programmes. A significant part of his work is focused on transitional regions in Eastern Europe and in Asia and Africa. His expertise also covers the field of health programming in the criminal justice, law enforcement and the penal system.

Jonas von Hoffmann is a Research Fellow at the German Institute for Global and Area Studies (GIGA) and its Institute for Latin American Studies (ILAS). Previously he was a Visiting Research Professor at the Center for Research and Teaching in Economics (CIDE) and a collaborator in its Drug Policy Program (PPD). Jonas holds a DPhil in Politics from the University of Oxford. His research and publications focus on various aspects of drug policy, specifically the processes and outcomes of cannabis regulation in Latin America.

Jonathan P. Caulkins is the Stever University Professor of Operations Research and Public Policy at Carnegie Mellon University's Heinz College and a member of the National Academy of Engineering.
Dr. Caulkins specializes in systems analysis of the supply chains supporting illegal markets, particularly problems pertaining to drugs, crime, terror, and prevention. Issues surrounding opioid markets and regulation, COVID-19 and cannabis legalization have been a focus in recent years, including co-authoring Marijuana Legalization: What Everyone Needs to Know (Oxford University Press).
Dr. Caulkins is a past Co-director of RAND's Drug Policy Research Center, founding Director of RAND’s Pittsburgh office and continues to work through RAND on a variety of projects.

Jon Findlay is the National Harm Reduction Lead for Waythrough. He has worked in and around services for people who use drugs for 24 years.
Jon started out in the prison service at HMP Manchester in the late ‘90s. He went on to manage one of the first versions of criminal justice drug treatment offers that were the precursor to the Drug Treatment and Testing Orders and subsequent Drug Requirement Orders.
Within Waythrough, Jon is now responsible for overseeing the national charity’s harm reduction services. These include needle syringe provision, clinical alerts, naloxone, safe inhalation, chemsex, emerging drug trends, and image performance enhancing drugs hormone clinics.
“For me harm reduction is an unconditional act of kindness and love not based on any requirement of compliant behaviour. Its about making today better.”

José Ignacio Nazif-Munoz, PhD, is Assistant Professor at the Faculty of Medicine and Health Science at Université de Sherbrooke, Québec. He holds a researcher-fellowship Junior 2, from the Fonds de recherche du Québec – Santé and the CRMUS Chair on the Evaluation of Public Policies Governing Alcohol and Cannabis Consumption in Quebec. His research interests lie in the intersection of sociology, substance use, and epidemiology with attention to public policy evaluation tools and their effects on vulnerable populations. He is advancing new research questions regarding the consequences of cannabis liberalization policies. He has more than 60 peer-review articles on high-impact journals such as Addiction, International Journal of Drug Policy, Epidemiology, Punishment and Society and Child Abuse & Neglect.

Political Scientist, Master Degree in Biostatistics and PhD in Public Policy. My research is focused on substance use disorder treatment. I'm a mixed method enthusiast with special interest in mixed-sampling designs.

Professor of Justice at LJMU, previously British Academy Global Professor in Department of Criminology, University of Manchester and Professor and Acting Dean, School of Public Policy, Central European University, Budapest. Member of the Eurasian Harm Reduction Association advisory board. A Latin Americanist by background with an interest in the gendered and development impacts of criminalisation and enforcement.

PhD. in political science from the University of Sorbonne ( Paris 1 Panthéon -Sorbonne ). Master in International Relations at the same university - master's thesis laureate - and bachelor degree in Economics and International Business at the University ICESI ( Cali, Colombia ). My PhD thesis deals with the conflict in the adaptation of the international norms on drugs within the Colombian legal system. I am mainly interested in the study of peace, the sociology of international norms, international drug control policy, conflicts of legal pluralism, analysis of foreign policy and indigenous mobilizations. Fellow of various organizations among them: the Mediterranean Shipping company MARMEDSA, COLFUTURO, ECOPETROL , the Regional Council of Ile de France.

Dr. Julie Loslier holds a master's degree in clinical research, a doctorate in medicine and a specialty in public health and preventive medicine from the University of Sherbrooke (2006). She also completed a subspecialization in social health inequalities at the University of Montreal (2008) as well as a FORCES fellowship from the Canadian Foundation for Health Services Improvement (2015).
She has worked at the Montérégie Public Health Direction since 2008, and has been Regional Director of Public Health there since 2016. She is also a full professor in the department of community health sciences at the Faculty of Medicine of the University of Sherbrooke, and associate researcher at the Charles-Le Moyne Research Center. In addition, Dr. Loslier is president of the cannabis vigilance committee of the Government of Quebec and vice-president of the scientific council of the National Institute of Public Health of Quebec.

Karen A. Domínguez-Cancino, PhD, is a researcher at the School of Nursing, Universidad San Sebastián. She recently completed her postdoctoral fellowship at the Service sur les Dépendances, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Canada. Since 2019, she has served as Deputy Director of the South American Affiliate Group of the Joanna Briggs Institute, leading and supporting the development of new research and evidence syntheses. Her research interests focus on public policies related to substance use, health services research, and gender studies.

I am Reader in Sociology at the School of Geography, Politics and Sociology (GPS), Newcastle University, UK. I have been researching and writing about illicit drugs, rave/dance music cultures, and youth leisure for over 20 years. I have also written about emerging drug trends, markets, laws and policies, alongside gender, drugs and technologies.

Kari Lancaster is Professor in Social Studies of Science and Health, in the Department of Social and Policy Sciences, at the University of Bath. Her research is informed by Science and Technology Studies (STS), public health sociology, and policy studies, with a focus on the critical social study of science and evidence-making practices in relation to health. Professor Lancaster is recognised for contributing theory-informed, as well as theory-innovating, empirical social science research in her specific fields of focus (health, drugs and addiction, and infectious disease including hepatitis C, HIV, and Covid-19). Her current work explores the relations between science, policy, evidence and intervention amidst transformative global changes affecting health, with a focus on outbreak and viral elimination. Professor Lancaster is Editor of Science, Technology & Human Values.

Kat Petrilli began working as a postdoctoral research associate at King's College London in September 2024. They work with Professor Sir John Strang in the Policy Research Unit in Addictions conducting research focused on enhancing the knowledge, access, and distribution of naloxone, a potentially life-saving medication for opioid overdoses.

In addition to their role at the Policy Research Unit in Addictions, Kat is a Senior Researcher at the Institute of Alcohol Studies.

Kawal Deep Kour is a Narcotics Research Scientist-Prevention and Policy with the Institute for Narcotics Studies and Analysis, New Delhi, India. Her work is focussed on prevention strategies and policy development related to narcotic substances. She has authored three books on the history and economics of opium and has many paper publications. Dr.Kour was inducted into the Network of Experts of the Global Initiative Against Transnational Organized Crime (GI-TOC) in 2024.
Dr. Kour is presently working on a Study on Illicit Drug Market Disruption Strategies - their impact, challenges and opportunities for improvement in collaboration with Anti-Narcotics Task Force (ANTF), Delhi.

Kim Gannonis a PhD Candidate at Yale School of Public Health, Department of Health Policy and Management. Her current work explores the effects of punitive drug policy on the health and well-being of people who use drugs in the United States, particularly members of historically marginalized racial and ethnic communities. She received her BS in Economics, Mathematics, and Statistics from Michigan State University.

Assoc. Prof. Lanying Huang, Ph.D. is a criminologist and a former police officer who got her degree at the School of Social Sciences, University of Manchester, UK. She is currently an Associate Professor at the National Taipei University and an Adjunct Associate Professor at the National Taipei University of Nursing and Health Sciences. She has published on a variety of topics such as policing, substance abuse, human trafficking, victims of violent crime, green criminology, and restorative justice. These topics surround her academic focus on researching vulnerable groups in Taiwan as offenders, victims, or practitioners, in the criminal justice system by qualitative methods. She is also a co-author of Policing in Taiwan: From authoritarianism to democracy (Routledge, 2014).

Larissa Steimle is a social worker currently working as a research assistant at the Institute of Addiction Research at Frankfurt University of Applied Sciences. Further, she is completing her doctorate on the topic of professional, supportive relationships in the context of crisis interventions. As a social worker she worked five years with people with mental illnesses. Her main areas of research include topics related to mental illnesses/drug use, professional social work and tobacco harm reduction.

Eriksson is an historian working within the field of Public Health Sciences. Her main research interests is policies aimed at people who use drugs in general and measures aiming at harm reduction in particular.

Liesbeth Vandam is Head of the Policy and Society Sector at the EUDA (European Union Drug Agency). Liesbeth holds a master's degree in European criminology and criminal justice systems, and a PhD in Criminology, focusing on drug use among people in prison (Ghent University, Belgium). Liesbeth started her professional career at the Institute for International Research on Criminal Policy in Belgium and joined the EMCDDA in 2011 as analyst in the scientific coordination department. She has (co-) authored several scientific and other publications on illicit drug monitoring, cannabis policies, drugs and prison, drug policy evaluation and drug related crime.

Dr Lindsey Metcalf McGrath is a Senior Lecturer in Criminology at Liverpool John Moores University. Her current research interests are focused on the experiences of people who need cannabis medicines. She has a particular interest in the stigma and social harms arising from drugs policy.

Lisa Williams is a Senior Lecturer in Criminology, at the Department of Criminology, School of Social Sciences, University of Manchester. She has been researching drugs for over 25 years. Her interests revolve around: recreational drug taking, including why people take drugs and how their drug taking changes over the life course; dependent drug use, recently publishing about synthetic cannabinoids consumption among vulnerable populations; and creative research methods, especially arts-based and visual techniques. Since 1999, she has worked on the Illegal Leisure longitudinal study exploring changing drug patterns from adolescence to adulthood. The findings have been published in Illegal Leisure Revisited and Changing Lives, Changing Drug Journeys. Her recent projects include, a visual ethnography of where and how people store their recreational drugs in the home, which has been exhibited nationally and internationally, and a cross stitch public engagement project, creating, with people who use drugs and the public, cross stitches with empowering and harm reduction messages.

Liviu Alexandrescu is a lecturer in criminology at Manchester Metropolitan University and a core member of the newly established Drugs, Policy and Social Change (DPSC) research centre. His research explores drug policy, stigma, and the socio-political dimensions of substance use. He also holds a broader interest in critical criminology and cultural analysis, including the role of popular media in shaping the crime imaginary. Previously, Liviu has held teaching and research positions at Oxford Brookes University and Lancaster University.

Margot Balcaen completed her master in pharmaceutical sciences in 2020. Afterwards, she joined the Drugs Unit of Sciensano. She has expertise in different aspects of the drug phenomenon, including the drug market and available substances, trends and evolutions in the drug situation, and possible public health implications. She coordinated projects such as the online survey Drug Vibes among people who use drugs, SCANNER, a project zooming in on new psychoactive substances and RADAR, the project looking into the quality and profile of retail level heroin in Belgium. She is also involved in the Belgian Early Warning System on Drugs. Overall, she has a strong interest in developing innovative monitoring methods for increased drug intelligence.

I am an MA Applied Criminology student at Manchester Metropolitan University (MMU).
During and since completing my BSc Criminology and Sociology with Quantitative Methods with a First Class Honours in 2024, I have worked as a research assistant within the Drugs, Policy and Social Change (DPSC) Research Group within MMU. I have been an Associate Lecturer from September 2024 within the department teaching all things drugs, quantitative methods, and theory.

Dr Marianne Jauncey is a Public Health Physician who has worked at the pointy end of harm reduction for decades. She has been the Medical Director of the Uniting Medically Supervised Injecting Centre (MSIC) since 2008. When MSIC opened it was the first supervised injecting centre in the English-Speaking World and for nearly a decade the only service of its kind in Australia. This service has been continuously operating since 2001 and supervised over 1.3 million injections without a single death, intervening in over 11,600 overdoses. Dr Jauncey is committed to ensuring Uniting MSIC provides unwavering support and meets the needs of its clients beyond merely supervised injection. Marianne is proud of the influence that she and her service have had within Uniting, the services and advocacy arm of the Uniting Church in NSW/ACT that holds the licence to operate the MSIC. In 2018, Uniting formally decided to advocate for drug law reform and increasing funding for treatment services, launching their campaign at Town Hall with Richard Branson. Marianne knows that ‘Language matters!’ To effect attitudinal and policy change, the narrative about people who use drugs needs to be framed by fairness, equity, and compassion. To this end Marianne has conducted countless media interviews and community led conversations to improve understanding about harm reduction and the nature drug use. She is passionate about improving the lives of people who use drugs and is always keen to get people taking about ways to make this happen.

Marie Jauffret-Roustide is a Sociologist, Research Fellow at Inserm, Paris, France. She is a member of the ISSDP board and of the EUDA scientific committee. She is the scientific director of the D3S Social science, drugs and policies research network. She leads comparative drug policy research on harm reduction in France and in North-America. She is particulary interested in exploring the methodological an epistemological issues in participatory-based approaches.

I am a Chilean PhD candidate at Griffith University (Australia) and a researcher at the Millennium Nucleus for the Evaluation and Analysis of Drug Policy (Chile). My research focuses on the intersection of substance use, trauma, and offending in Chile.

I’ve worked in the drugs field for over twenty-five years. Spending about half of that in research and the other in commissioning. As my job title suggests, my role at GMCA is primarily a strategic one, working with commissioners and partners across health and justice, trying to ensure we provide the best services we can, in what are often challenging circumstances. I’m particularly proud of the drugs intelligence system we have built up over the years and will hopefully get to talk about that.

Mark Whitfield is a Reader in Substance Use at LJMU's Public Health Institute, and leads the Institute's Intelligence and Surveillance team who are commissioned to provide surveillance systems across England and Wales around their twin specialisms of injury prevention and substance use. In recent years he has overseen the roll-out of the IMS model for reviewing drug and alcohol related deaths to every local authority in the north-west of England along with Birmingham and Solihull. Mark has a background in the field of drugs and alcohol having worked for 12 years originally within the scope of a local Mental Health NHS Trust, involving face to face work with people who use drugs in a needle exchange setting. Mark is the chair of the National Drug Related Deaths Intelligence Group.

Marta Rychert (PhD) is an Associate Professor at the SHORE & Whariki Research Centre. Her work lies at the intersection of health, policy and law, with particular focus on drug policy, cannabis markets (recreational and medical) and their commercialisation. She is a co-Editor-in-Chief of international journal "Drugs, Habits and Social Policy". Prior to her academic appointments in New Zealand she worked in the European Union Drugs Agency in Portugal.

Martine Skumlien is a postdoctoral research associate in the Addictions Policy Research Unit at King’s College London. Her current research is focused on exploring how to increase access to and carriage of naloxone and developing new measures of naloxone delivery. She completed her PhD at the University of Cambridge where she investigated the association between acute and chronic cannabis exposure and reward processing in adults and adolescents, using behavioural and neuroimaging methods. She has also previously led mixed-methods research into the need for drug checking and detection of novel psychoactive substances, particularly synthetic cannabinoids, at the University of Bath.

Matthew is an interdisciplinary researcher with expertise in policing, drug policy and qualitative research methods. His main area of research is drugs policing. He is interested in exploring the complexities of the police operating environment and how policing interventions are conducted, to promote enhanced understanding of their role and impacts. His recent research is concerned with innovation and reform in drugs policing, especially alternatives to criminalisation and other harm reduction measures at the interface between law enforcement and public health.

Maximilian Schaefer, MScPH is a research assistant in the Department of Epidemiology, Biostatistics, and Occupational Health at McGill University, Montreal, Canada. His research focuses on the impact of harm reduction interventions.

Meropi Tzanetakis is an Assistant Professor in Digital Criminology at the University of Manchester. She had over a decade of experience in societal security research across universities in the UK, Austria, Germany, and Norway. Her pioneering research focuses on the socio-technical aspects of digital drug markets, the business models of digital platforms, and interdisciplinary projects on inclusive AI, trust, security, and governance.

Michael Armstrong is an associate professor of operations research at Brock University in Canada. His research examines the economic aspects of cannabis legalization.

Dr Michala Kowalski is a Postdoctoral Research Fellow at NDARC, UNSW. She was awarded her PhD in 2024, for her mixed-methods study of alcohol policy in New South Wales, which examined the role of evidence in policy, the leading problematisations in alcohol policy, and analysed overlooked effects of alcohol policies in New South Wales.
Michala’s current research program concentrates on alcohol policy, cannabis policy, evolving drug markets, and harm reduction. She is an active member of the Global Cannabis Cultivation Research Consortium, and the Drug Policy Modelling Program Network.

Mohammed Abul Kalam, PhD, MA, MSc, MPH, PG Diploma, MSS, is the Chief Research & Development Officer of Quick Health Service Center (QHSC), Rajshahi, Bangladesh. He leads teams of researchers working in the field of behavioral and social sciences interacting with health and diseases (e.g., communicable and non-communicable diseases, Sero- and behavioral surveillance of STD/HIV/AIDS/HCV, public health surveillance, drug abuse, disease outbreak investigation…). He supervises the thesis and dissertation as an external examiner. He is a prolific writer and published more than 217 scientific articles, essays, monographs, & study reports on health, population & development from home & abroad. He regularly contributes articles in the national English dailies on health, population, climate change, development & contemporary issues (published 389 articles so far).
Before joining this present organization (Quick Health Service Center), he worked as Director (Research & Development) at Siam Health Care, Dhaka, Bangladesh from 2013 to 2019. He also served as Founding Head of, the Department of Medical Sociology at the Institute of Epidemiology, Disease Control & Research (IEDCR), Dhaka, Bangladesh under the Ministry of Health & Family Welfare from May 1993 to December 2012. IEDCR is an apex public health institute of the Government of Bangladesh, and Dr. Kalam discharged responsibilities in public health matters–public health, epidemiology, research ethics, harm reduction, research, teaching, disaster management, general management functions…

Dr Monica Barratt is a senior drugs-policy researcher at RMIT University. Her work investigates digitally facilitated drug trading, new psychoactive substance trends and markets, drug checking or pill testing, and ways to increase meaningful involvement of people who use drugs in research and policy processes.

Dr. Nur Afiqah's research examines institutional-related structures associated with engagement in healthcare, including HIV and Hepatitis C care for people who use drugs (PWUD). This epidemiological work is informed by sociological perspectives which frame the research questions within a wider social, economic and policy environment. Additionally, she has received training in Implementation Science at Yale University.

Being an active member of the Centre of Excellence for Research in AIDS (CERiA), her current research activities have incorporated a community-based participiatory research (CBPR) component. Using this approach, she engages with local communities of PWUD and NGOs that serve these populations, whose collective views in the design and implementation of health programs are key in developing effective interventions. Additionally, she is actively involved in knowledge-transfer activities, promoting the use of evidence-based practices in real-life settings. She is also interested in drug policies, especially the impact of existing policies on youths and families.

She currently serves as the Vice President at the Malaysian AIDS Council.

Sociologist from Chile. My academic interests are harm reduction, pleasure management, youth culture, and cinema.

I am a PhD student in criminology at the University of Manchester, UK. I am interested in the research area related to drug policy, particularly on the relationship between international drug policy, national drug policy and criminal justice practices. My research project focuses on understanding the processes involved in international drug policy-making through the study of interaction of inter-governmental systems in the international drug policy debates. Through a case study approach on Malaysia and Singapore, I seek to explain the roles of countries with traditional drug policies at the Commission on Narcotic Drugs. Currently on my study leave, I have served 14 years in the Malaysian public service in which close to 8 years were spent in drug policy.

Colombian lawyer and activist with more than 10 years of experience in human rights, drug policy and transitional justice. She is a member of IDPC's Advisory Council as representative of Latin America and the Caribbean. She is currently the director of Elementa's office in Colombia.

Elementa is a feminist organization that works from a socio-legal and political approach, to contribute to the construction and regional strengthening of human rights through its offices in Colombia and Mexico. Elementa's areas of work are 1) truth, justice and reparation; 2) drug policy and human rights.

Master's Student, University of British Columbia
Bachelor's in Medicine, University of Sao Paulo, Brazil

I am one of Australia's leading alcohol and other drugs researchers with a strong track record in conducting research that has impacted drug policy in Australia and internationally.

Dr Paul Kelaita is a postdoctoral fellow in the Drug Policy Modelling Program at the Social Policy Research Centre. He works on values in drug policy, focussing on policymaker and alcohol and other drug sector approaches to debate and reform. Paul is currently researching: how values inform drug policy debate; the NSW Drug Summit; the conditions of support for drug policy reform; and models of drug regulation.

Petr Zeman, LL.M., Ph.D.
Petr Zeman is a lawyer working at the Institute of Criminology and Social Prevention (IKSP) in Prague. He graduated in 1997 as a Master of Laws (LL.M.) at the Law Faculty of Charles University in Prague. In 2000 he completed a Ph.D. degree in Criminal Law, Constitutional Law and Criminology at the same University. After one-year practice as a candidate attorney he joined IKSP, the leading workplace of criminological research in the Czech Republic. In 2005 he became a senior researcher at IKSP and since 2012 he has acted as a Head of Research Section. In 2020 he was appointed Director of IKSP. His main fields of professional interest include drug-related crime; drug policy; the treatment of dangerous offenders and the functioning of the criminal justice system.

Pieter Oomen (MSc in Pharmacy and PhD in Analytical Chemistry from the University of Groningen, the Netherlands) has been working as a researcher at the Trimbos institute since 2020. He is involved with different drug market monitoring projects, such as the Drug Information and Monitoring System (DIMS) and the annual coffeeshop monitor. His research interests are neuropsychopharmacology, cannabis, NPS and analytical techniques.

Rachel works within the Centre for 21st Century Public Health as a researcher for the Local Health and Global Profits Research Consortium, a multi-university, multisectoral project focused on how to improve health and equity at local level in the UK. I am also Vice President of the International Confederation on Alcohol, Tobacco and other Drug Research Societies (ICARA).

I am internationally recognised for my research on cannabis regulation and its implications for health (and broader agendas such as crime and finance) and on cannabis and related industries. With expertise in questions around policy coherence and coordination, my work focuses on three main areas:

Exploring the barriers and facilitators for developing coherent approaches to regulating the supply of unhealthy commodities and the conduct of companies that manufacture these products, notably cannabis, tobacco, alcohol and e-cigarettes.

Understanding how complex systems of overlapping global, regional and national policies shape and constrain implementation of national health policy innovation.

Developing evidence to inform innovation in cannabis governance by drawing on historical and contemporary lessons from regulating the global tobacco and alcohol industries.

Ralph Mennes is senior researcher and consultant at Breuer&Intraval, an independent research and advisory firm with over 30 years of experience on coffeeshop policy. With more than a decade of experience, Ralph has significantly contributed to various projects, particularly in the field of public policy and social research. Notably, Ralph has conducted extensive research on coffeeshops, providing valuable insights into their social and environmental impacts. He is also one of the lead researchers on the Closed Cannabis Supply Chain Experiment in the Netherlands, an initiative of the Dutch government aimed at regulating and studying the cannabis market.

As a trained medical anthropologist, my research focuses on how health disparities, particularly class, gender, race, and ethnicity, contribute to producing and reproducing health inequalities in marginalized populations. I have conducted extensive research on health disparities, HIV/HCV, and overdose risks among people who inject drugs in Puerto Rico, a US territory. I am interested in understanding the everyday lives of people who inject drugs (PWID) and how colonialism, poverty, dispossession, and racism shape their injection behaviors, HIV/HCV and overdose risk, and other drug-related harms.

Rob Ralphs is a Professor of Criminology and Social Policy and Deputy Director of the Drugs, Policy and Social Change (DPSC) Research Centre at Manchester Metropolitan University. He has over 25 years drug related research experience that has spanned substance use, drug markets, drug policy and treatment responses. This has incorporated researching drug dealing gangs, prison drug use and markets, homelessness and substance use, image and performance enhancing drug use, new psychoactive substances, heroin, and crack cocaine, chemsex, ‘club drugs’, and evaluating and developing treatment responses.

Rosalie Liccardo Pacula, Ph.D. holds the Elizabeth Garrett Chair in Health Policy, Economics & Law in the Health Policy and Management Department at the USC Sol Price School of Public Policy, where she is also currently serving as Chair of the department. Dr. Pacula also co-Chairs the National Academy of Sciences, Engineering and Medicine (NASEM) Forum on Mental Health and Substance Use Disorders and is a Research Associate at the National Bureau of Economic Research. She also serves as the Co-PI on the RAND-USC Schaeffer Opioid Policy Tools and Information Center of Excellence (OPTIC), a P50 Research Center in its 7th year of support from the National Institute on Drug Abuse, which seeks to increase the pace of scientific research that can identify cost-effective strategies for reducing the harms caused by the opioid crisis in different communities.

Rosanna Smart is a senior economist at RAND, codirector of the RAND Drug Policy Research Center, codirector of the RAND Gun Policy in America initative, and affiliate faculty of the Pardee RAND Graduate School. Her research is in applied microeconomics, with a focus on issues related to health behaviors, illicit markets, drug policy, and the determinants of gun violence.

I’m a Senior Lecturer in the Dept. of Population Health, at the University of Otago (Christchurch campus). My research takes a public health approach to drug harm, and is focussed on understanding and preventing drug harm, and how harm data can inform evidence-based drug policy

xxx

I am a Research Scientist at the Public Health Institute and a Lecturer in Medical Anthropology at UC Berkeley. I work to advance health equity and improve health systems. My current projects aim to diagnose commercial determinants of health that reinforce disparities.

I earned a PhD in the UCSF-UC Berkeley joint program in medical anthropology (2018), and completed postdoctoral training in global health at The Graduate Institute in Geneva, Switzerland (2018-22).

Dr Molinaro is Research Director at the Italian National Research Council, where she leads the Department of Epidemiology and Research on Health Services. Since 2016, she has been the Coordinator of the European School Survey Project on Alcohol and Other Drugs (ESPAD).
For over 10 years, she has been studying drug and behavioral addictions through various sources of information, surveys, economic data, and clinical data.
The crucial aspect of her research is to promote dialogue among diverse disciplines with the aim of integrating different skills and heterogeneous data sources. Her research can be summarized in three main areas: Population Studies to Monitor Health Risk Behaviors in At-risk Populations; Development of Analysis Models for the Healthcare System and Precision Medicine; Evaluation of Health Policies through Innovative Econometric Models.
Dr. Molinaro has conceived and directed numerous research projects, including competitive projects at the European and national levels. She has published more than 100 international research articles in leading scientific journals and numerous book chapters.

Samantha Pérez Dávila is a Ph.D. student in the Research, Analysis, and Design stream at Pardee RAND Graduate School and an assistant policy analyst at RAND. She has a master's degree in applied economics from Johns Hopkins University and a bachelor's in economics and finance. At RAND, she works on topics related to drug policy, opioids, security, and mental health.

Sam Shirley-Beavan recently completed his PhD in Social Policy at the University of Kent. His doctoral project was an ethnographic investigation into harm reduction among street-based people who use basuco (a form of smokeable cocaine) in Bogotá, Colombia.

Dr. Sanna Rönkä is a Senior Specialist at the Finnish Institute for Health and Welfare (THL) in Helsinki, Finland. She is currently working on the research project "Out of Despair," which focuses on drug-induced, violent, and suicidal deaths, as well as near-miss cases among young people under 30. Her research interests include drug-related mortality, the social determinants of drug use and mortality, and the non-medical use of prescription drugs.

Sarah is a PhD student at the University of British Columbia in Political Science. Prior to commencing a PhD, she worked as a lawyer and maintains her membership with the Law Society of British Columbia, Canada. Her research explores the legal and political processes of drug policy reforms within Canadian administrative institutions.

Sarah Larney is an Associate Professor at the Université de Montréal and Principal Researcher, Centre de recherche du centre hospitalier de l'Université de Montréal. Her work focuses on the epidemiology of drug use and drug-related harm including infectious diseases and mortality.

Dr. Sznitman received her B.A. in sociology from the University of Manchester and her M.A. and Ph.D. in sociology from Stockholm University. She then completed a Postdoctoral Research Fellowship at Annenberg Public Policy Centre at the University of Pennsylvania. In 2010 Dr. Sznitman joined the School of Public Health at the University of Haifa where she is a senior lecturer.

Dr. Sznitman’s most recent research mainly focuses on medical cannabis use and policies in Israel and in cross-national contexts. Her research focuses on how both medical and recreational users use cannabis to ease mental and physical pain. Her research also focuses on reaching a better understanding for how public attitudes influence medical cannabis policy development and implementation in Israel and abroad, and in turn how medical cannabis policies (mainly through the media) influence the general population and its attitudes not only to medical cannabis but also recreational cannabis use. Medical cannabis policies are developing rapidly in many jurisdictions across the world, with implications for medicine, public health, business and policy. Dr. Sznitman’s research provides an important platform from which these expected effects can be determined and how societies may best respond.

Dr Simone Henriksen is an academic legal researcher and Associate Lecturer in Law at the University of the Sunshine Coast, Sippy Downs Queensland. Simone has a diverse academic background, holding a PhD in Law and a Bachelor of Pharmacy. After completing her Bachelor of Pharmacy at the University of Sydney in 1987, Simone pursued a career as a community pharmacist in regional Queensland. Driven by her interest in the legal aspects of healthcare and a desire to contribute to the broader societal understandings of these issues, Simone pursued further education in law. Simone’s main research area focuses on the regulation and governance of alcohol and other drug treatment services in Australia. Her work has highlighted the complex governance structures operating in the alcohol and other drug treatment sector in Australia and the issues surrounding the quality and safety of treatment services. Simone’s research interests also include legal barriers to access to medicines.

Professor Simon Lenton is a researcher at the National Drug Research Institute and works as a Clinical Psychologist in private practice. He has been researching and writing on drug policy since 1994.

Sophia is an MA student in Counselling Psychology at McGill University (Montreal, Canada) under the supervision of Dr. Dennis Wendt. She pursued two undergraduate degrees concurrently and obtained both a BSc in Behavioral Neuroscience and a BA in English from Simon Fraser University in 2022. Following that, Sophia worked with Dr. Eugenia Oviedo-Joekes studying the uptake, accessibility, and implementation of injectable opioid agonist treatment (iOAT, or prescription injectable heroin) in clinics across downtown Vancouver. Her research interests include person-centered substance use care, safer supply, and perinatal substance use.

Sophie is a PhD student in Criminology at the University of Manchester conducting research on Canadian drug policy, specifically the regulation of cannabis for recreational use and Canada's public health approach to drug use. She also has experience researching drug economies at the Royal United Services Institute (RUSI) and more recently for the Canadian Centre on Substance Use and Addiction. Prior to her PhD, Sophie was a policy analyst at the Government of Canada.

Since 2000 Stacey has significant experience in the sector, spanning drug education, treatment, therapeutic interventions, volunteer and peer support, training and workforce development. This was recently consolidated by completion of an MSc with Distinction in Mental Health and Substance Misuse.
Her qualitative study explores the transitions of people with lived experience of addiction, from accessing
services to working in them. Following successful submission of a research proposal focusing on the integration of lived and living experience into the workforce, she has been offered a PhD at the University of Birmingham which she hopes to begin pending funding this year. Stacey currently offers training and consultancy in substance use and mental health and is pursuing opportunities as an early career researcher.

Stijn Hoorens is a Senior Research Leader at RAND Europe, a researcher at the RAND Drug Policy Research Center, and director of RAND’s office in Brussels. Since starting at RAND almost two decades ago, he led numerous studies on drug and other illicit markets and evaluations on (inter)national drug policies.

Professor Suzanne Nielsen (BPharmSc[Hons] PhD MPS) is a registered pharmacist, Deputy Director of the Monash Addiction Research Centre in Melbourne, and an NMHRC Leadership Fellow. Her research focuses on understanding prescription, over-the-counter and emerging drug-related problems, and identifying effective policy and practice interventions to reduce opioid-related harm.

Sydney Ambury (she/her) is a Master of Social Work student at Lakehead University and a Registered Social Worker. Based in Northern Ontario, Canada, she is a practicing psychotherapist and advocates for harm reduction in clinical and community settings. Her research explores substance use, harm reduction, and community-based responses to addiction across Ontario, with a focus on Northwestern regions.

Teresa graduated in Social Work in 2016 and is currently working as a social worker at GAT IN Mouraria in Lisbon, Portugal, a harm reduction drop-in center and drug consumption room. As a drug user herself, she has been involved in harm reduction since she was 18, initially in nightlife settings and later with more vulnerable communities. She has been a peer collaborator at Kosmicare since its foundation, an organization that offers peer-based harm reduction, drug checking, and psychological support services. Additionally, Teresa is also a member IDPC's Peer Review Group.

Thomas is Associate Professor, at Centre for Alcohol and Drug Research, Aarhus University, and has a special interest in drug markets and drug policy.

Dr Thomas Martinelli is an anthropologist and criminologist with a special interest in drug-related topics
and qualitative research among people in vulnerable situations. In 2023 he obtained his PhD for research into the concept of drug addiction recovery. At the Trimbos Institute he is a scientific employee in the international Drugs, Monitoring and Policy Program and he is co-organizer of the Dutch Harm Reduction Network. His current work includes studying substance use in detention settings and developing and analyzing (international) drug policy tools.

Tobias Kammersgaard is an Assistant Professor at the Centre for Alcohol and Drug Research, Aarhus University, Denmark. His research focuses on drug policy-making and drug law enforcement, with an emphasis on harm reduction and improving conditions for people who use drugs.

Toby Seddon is Professor of Social Science at University College London and Head of the UCL Social Research Institute. He has been teaching and researching in the areas of drugs and criminal justice policy for over 30 years.

Tuulia Lerkkanen is a PhD student at the Department of Public Health Sciences at Stockholm University.
Her PhD project inquires into stakeholder interests in drug policy development in Sweden. Her research interests include drug policy, substance use, public health policy, and media.

Psychiatrist
Medical Doctor
Master of Science
Bachelor of Physical Health and Education

Vicki has been working with people using drugs for over 23 years. She has worked within the drug and alcohol sector for a range of statutory and non-statutory organisations and was until recently the Chief Executive of Project 6 in Yorkshire, one of the last harm reduction rooted organisations in the country. She is passionate about harm reduction, involving people who use drugs in research/ practice and improving the rights of people who use drugs.

Vicki is now a PhD candidate at the University of Manchester, where her research focuses on women's access to drug treatment, the co-design and co-production of research with people who use drugs and the impact of neoliberalism on the drug and alcohol treatment sector.

She is vice-chair of Collective Voice, the national charity that represents the drug and alcohol treatment sector, vice-chair of Transform Drug Policy Foundation and a fellow of the Royal Society of Arts. She is a member of the European Harm Reduction Network Correlation and of the Women's International Harm Reduction Network.

Winnie Agnew-Pauley is a Postdoctoral Research Fellow at Simon Fraser University’s School of Criminology, where she researches the policing of drug decriminalization in British Columbia, Canada. She completed her PhD at Flinders University (Australia), examining the police use of stop and search in England, using a critical realist and ethnographic approach. Her research interests focus on the policing of drugs and drug policy reform.

​Yong-an Zhang is Professor and Director of the International Center for Drug Control Policy Studies (ICDPS) at Shanghai University. Dr. Zhang’s research interests include the international drug control policy, and China’s drug control strategy. He is member of the Executive Committee of Alcohol and Drugs History Society (ADHS), and a member of Editorial Board of The Social History of Alcohol and Drugs. His previous positions include visiting fellow of Center for Northeast Asian Policy Studies (CNAPS) at the Brookings Institution (Fall 2010), visiting professor of History of Medicine at Yale University’s School of Medicine (2009-2010), visiting professor at the Centre for the Social History of Health and Healthcare (CSHHH) (Glasgow, UK) since 2016, and Foreign Senior Fellows of the The HK+ Institute for Integrated Medical Humanities at Kyung Hee University since 2024. Dr. Zhang is editor-in-Chief of the International Medical Hisotrical Review, and the Blue Book on International Drug Control Series, and he has published articles on these issues in both English and Chinese. His latest study is: Between Science and Politics: The American Medical Association and Origins of Drug Control, 1847-1973 (2016); Policy Choice in Changing Society: A Study on American Marijuana Policy (2009).​

Black Lives Matter Paterson Organizer

Zoë Welch is Head of Research at Change Grow Live, a national third sector provider of drug and alcohol treatment services. With over 20 years’ experience as a drug and alcohol researcher and national research lead in charities, Zoë has a deep understanding of the sector and the strength the third sector holds in translating research evidence into practice. Her role is at the interface between first-line service provision and academia which ensures findings are relevant and implementable in policy and practice. Her current projects include NIHR and MRC funded projects ranging from the facilitation of clinical trials to participatory research and evaluation of innovative approaches to support people who use drugs.